-
How an alleged monkey smuggling scheme can stifle drug research
The National Association for Biomedical Research and other medical groups are urging federal officials to help amid a shortage of monkeys they say is disrupting research for lifesaving medications. -
Arizona nixes physician prescription requirement for birth control
Arizona passed a bill which allows pharmacists to dispense birth control with non-patient specific orders, the Observer Today reported March 30. -
FDA panel sets date for OTC birth control meeting
On May 9 and May 10, an FDA advisory panel will discuss whether to recommend the agency approve what could be the first over-the-counter birth control pill. -
J&J abandons RSV vaccine plans
Johnson & Johnson is stopping work to develop a respiratory syncytial virus vaccine for older adults — a move that will allow the company to "prioritize the most transformational assets for ongoing investment." -
'It's monumental': FDA approves 1st OTC naloxone nasal spray
The FDA approved the first over-the-counter Narcan (naloxone) product on March 29. -
Rural hospitals could soon have a harder time stocking drugs
As more drugs slip into shortage, rural hospitals could lose their failsafes as the healthcare industry grapples with dozens of inaccessible medications. -
Walgreens won't increase wages for some workers, CEO says
Some employees at Walgreens will not see any "further" wage increases, the chain's CEO said March 28. -
4 drugs are discontinued after US drugmaker closed
Four drugs listed as products with the greatest risk of supply disruption and vulnerability after a U.S. drugmaker closed in February are on back order. The U.S. now has no supply of four others. -
Antibiotic stewardship program shows promising results amid growing resistance: Study
Antibiotics are overprescribed or inappropriately prescribed between 30 and 50 percent of the time, according to a recent study, but the implementation of antibiotic stewardship programs in hospital settings can reduce costs and antimicrobial consumption significantly. -
South Korean company will expand its pharmaceutical footprint in New York
Closures and layoffs from some of the largest drug manufacturers in the U.S. have not rattled South Korean company Lotte Biologics from acquiring a pharmaceutical plant in Syracuse, N.Y., according to a March 27 report from syracuse.com. -
Roche's Genentech lays off 265 as plant closure nears
Genentech, Roche's biotech company based in South San Francisco, is closing a plant and laying off 265 workers, Mercury News reported March 25. -
Biden administration will not pursue action to lower cancer drug price
The Biden administration has denied a petition that would have reduced the price of Xtandi, a drug developed at the University of California, Los Angeles, to treat prostate cancer. -
Top 20 pharmacy schools by NAPLEX pass rates
The top pharmacy school ranked by passage rates of the North American Pharmacist Licensure Examination tests is outside the U.S., according to the National Association of Boards of Pharmacy. -
Drug delays resulting in patient harm, 340B Health report says
Low-income patients, rural communities and safety-net hospitals have been disadvantaged by restrictions placed on 340B discounts for drugs dispensed at community and specialty contract pharmacies, a new report said. -
A constant 'Whac-A-Mole' game: Experts testify on drug shortages
For about an hour and a half on March 22, four pharmaceutical supply experts outlined ideas to lawmakers to reform the nation's slippery access to critical drugs. -
UC San Diego and the 340B program: 4 numbers to know
As tensions heat up surrounding 340B, UC San Diego Health said the federal program — which aims to lower prescription drug prices for hospitals that treat low-income and uninsured patients — is a "vital lifeline." -
Ozempic shortage partially clears up
The monthslong shortage of Ozempic — a type 2 diabetes drug popularized by TikTok trends and celebrity use for its off-label use for weight loss — has seen a reprieve, according to the FDA. -
Essentia Health reopens pharmacy, surgery center after partial roof collapse of adjacent building
Essentia Health's Miller Hill surgery center and pharmacy in Duluth, Minn., are set to reopen March 22 after a roof collapse at the Miller Hill Mall where its facilities are located forced closure. -
New drug shortages increased 30% in 2022
Drug shortages, which increased nearly 30 percent from 2021 to 2022, pose health and national security risks, according to a new report from the Senate Committee on Homeland Security and Governmental Affairs. -
Biogen's ALS drug candidate shows mixed results; FDA panel weighs in
An FDA advisory panel voted for and against the clinical benefit of tofersen — Biogen's investigational drug for amyotrophic lateral sclerosis, which failed to pass its primary endpoint in a late-stage trial — on March 22.
Page 8 of 50